WHO Halts Use of Euvax B Vaccine for Hepatitis B (Vietnam)
This article was originally published in PharmAsia News
The World Health Organization (WHO) has suspended the use of the Euvax B vaccine for hepatitis B worldwide following the deaths of three infants in Vietnam. The vaccine was made by LG company in Korea but reportedly was imported without verification into Vietnam. A government group is investigating the cases and includes representatives of the National Institute of Hygiene and Epidemiology, the Expanded Programme for Immunization, the National Hospital of Pediatrics, the WHO, and UNICEF. (Click here for more
You may also be interested in...
Vibostolimab is less advanced than Roche’s competing tiragolumab, but Merck thinks the combo of its anti-TIGIT and Keytruda will offer a better therapeutic profile.
Ambitious efforts to make the EU more resilient to future challenges, such as health threats, drug supply problems, scientific advances and growing medicine costs, have taken a step forward with the publication of a roadmap for a wide-ranging Pharmaceutical Strategy to be adopted by the European Commission later in the year.
AdvaMed CEO Scott Whitaker shared a letter he sent to member companies voicing support for the ongoing protests around the US against police brutality that were sparked after the killing of George Floyd. “While we continue our single-minded pursuit of medical breakthroughs to treat and cure disease, we must also have a single-minded focus on eradicating the disease of racism in this country and around the world,” Whitaker wrote.